Dificid (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the Dificid drug offered from Merck Sharp & Dohme Corp.. This Macrolides [Chemical/Ingredient],Macrolide Antibacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | fidaxomicin |
| SUBSTANCE NAME: | FIDAXOMICIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Macrolides [Chemical/Ingredient],Macrolide Antibacterial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-27 |
| END MARKETING DATE: | 0000-00-00 |
Dificid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dificid from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2011-05-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52015-080_2dd1e338-2a3b-4f1c-9b5b-79262bbe93e6 |
| PRODUCT NDC: | 52015-080 |
| APPLICATION NUMBER: | NDA201699 |
Other FIDAXOMICIN Pharmaceutical Manufacturers / Labelers:
